Bariatric Surgery Associated with a Lower Rate of Mortality Due to Infarction and Stroke

Prior bariatric surgery in a patient with morbid obesity is associated with a significant effect on survival after infarction or stroke.

TAVI: la estrategia minimalista es favorable en el EPOC severo

While these are observational data, the significant metabolic improvement experienced after the surgery can explain perfectly such findings.

This large nationwide registry of bariatric surgery found a 40% decrease in the risk of death, infarction, or stroke for these patients compared with patients who did not undergo such surgery. This benefit is still observed after individuals are matched by body mass index (BMI). There already are many small studies showing similar data for obese patients who undergo bariatric surgery. Bariatric surgery has also proven to be an effective and durable treatment for type 2 diabetes, although the mechanisms for such effect are not entirely understood.


Read also: Nonobstructive Coronary Lesions and Ventricular Dysfunction


The US bariatric surgery database sponsored by the Agency for Healthcare Research and Quality assessed 995,577 patients hospitalized for acute myocardial infarction and 917,610 for stroke over an 8-year period. Of these, 2218 patients with infarction and 2,168 with stroke had undergone prior bariatric surgery. Those patients were compared with a control group of morbidly obese patients with the same risk characteristics using propensity score matching.

Death due to infarction was 1.85% in patients with prior bariatric surgery compared with 3.03% in morbidly obese patients (p = 0.004). Similar results were observed with stroke: 1.43% vs. 2.74% (p = 0.001).

An analysis using BMI to match patients showed nearly identical results.


Read also: New Percutaneous Devices to Prevent Embolism in Atrial Fibrillation.


Bariatric surgery should have never been seen as a cosmetic procedure, but rather a tool to treat metabolic disease.

Original Title: Bariatric Surgery is Associated with a Lower Rate of Death after Myocardial Infarction and Stroke: a Nationwide Study.

Reference: Aminian A et al. Diabetes Obes Metab. 2019 May 3. [Epub ahead of print].

Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

STEACS and the Use of Bivalirudin vs. Heparin: In Search of BRIGHT-4 Outcomes

Various studies and registries have previously shown the impact of post-percutaneous coronary intervention (PCI) complications on the survival of patients with ST-segment elevation acute...

TAVR and Atrial Fibrillation: What Anticoagulants Should We Use?

The prevalence of atrial fibrillation (AF) in TAVR patients ranges from 15 to 30%, depending on series. This arrhythmia has been associated to higher...

Ultrathin vs Thin-Strut Stents in PCI Patients at High Bleeding Risk

Several in vivo studies have shown that ultrathin stents present lower thrombogenic risk vs. thin-strut stents, which reflects in lower rates of target lesion...

Should We Withdraw Anticoagulation Before TAVR?

Approximately one-third of patients undergoing transcatheter aortic valve replacement (TAVR) have atrial fibrillation and are on oral anticoagulant (OAC) therapy. This creates a complex...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....